Login / Signup
Increased reporting of cerebrovascular accidents with use of risankizumab observed in the FDA Adverse Events Reporting System (FAERS).
Alexander Egeberg
Jacob P Thyssen
Published in:
The British journal of dermatology (2023)
Keyphrases
</>
adverse drug
emergency department
drug induced
drug administration